These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36519539)

  • 1. Soluble urokinase plasminogen activator receptor: from biomarker to active participant in atherosclerosis and cardiovascular disease.
    Goodchild TT; Li Z; Lefer DJ
    J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36519539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis.
    Hindy G; Tyrrell DJ; Vasbinder A; Wei C; Presswalla F; Wang H; Blakely P; Ozel AB; Graham S; Holton GH; Dowsett J; Fahed AC; Amadi KM; Erne GK; Tekmulla A; Ismail A; Launius C; Sotoodehnia N; Pankow JS; Thørner LW; Erikstrup C; Pedersen OB; Banasik K; Brunak S; Ullum H; Eugen-Olsen J; Ostrowski SR; ; Haas ME; Nielsen JB; Lotta LA; ; Engström G; Melander O; Orho-Melander M; Zhao L; Murthy VL; Pinsky DJ; Willer CJ; Heckbert SR; Reiser J; Goldstein DR; Desch KC; Hayek SS
    J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36194491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Urokinase Plasminogen Activator Receptor: Genetic Variation and Cardiovascular Disease Risk in Black Adults.
    Olson NC; Raffield LM; Moxley AH; Miller-Fleming TW; Auer PL; Franceschini N; Ngo D; Thornton TA; Lange EM; Li Y; Nickerson DA; Zakai NA; Gerszten RE; Cox NJ; Correa A; Mohlke KL; Reiner AP
    Circ Genom Precis Med; 2021 Dec; 14(6):e003421. PubMed ID: 34706549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble urokinase plasminogen activator receptor is associated with cardiovascular calcification in peritoneal dialysis patients.
    Guan J; Gong S; He Q; Wang X; Shen S; Wu X; Shan J; Gong T; Yang Y; Xie H
    Int Urol Nephrol; 2024 Jan; 56(1):191-198. PubMed ID: 37195572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease.
    Ismail A; Hayek SS
    Curr Cardiol Rep; 2023 Dec; 25(12):1797-1810. PubMed ID: 37948017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. suPAR in cardiovascular disease.
    Montecillo J; Pirker T; Pemberton C; Chew-Harris J
    Adv Clin Chem; 2024; 121():89-131. PubMed ID: 38797545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Urokinase Plasminogen Activator Receptor is Associated with Coronary Artery Calcification and Cardiovascular Disease in Patients Undergoing Hemodialysis.
    Wu W; Cui Y; Hu J; Liao R; Li S; Mo L; Xu L; Chen Y; Lian Z; Tian X; Li Z; Li R; Zhang L; Liang H; Ma J; Lin T; Feng Z; Dong W; Ke G; Ge P; Ye Z; Wang W; Zhang B; Shi W; Liang X; Liu S
    Kidney Blood Press Res; 2018; 43(3):664-672. PubMed ID: 29734173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
    Persson M; Engström G; Björkbacka H; Hedblad B
    Atherosclerosis; 2012 Feb; 220(2):502-5. PubMed ID: 22119508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control study.
    Rasmussen LJ; Knudsen A; Katzenstein TL; Gerstoft J; Obel N; Jørgensen NR; Kronborg G; Benfield T; Kjaer A; Eugen-Olsen J; Lebech AM
    HIV Med; 2016 May; 17(5):350-7. PubMed ID: 26365671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein.
    Hayek SS; Divers J; Raad M; Xu J; Bowden DW; Tracy M; Reiser J; Freedman BI
    J Am Heart Assoc; 2018 May; 7(9):. PubMed ID: 29716888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque.
    Edsfeldt A; Nitulescu M; Grufman H; Grönberg C; Persson A; Nilsson M; Persson M; Björkbacka H; Gonçalves I
    Stroke; 2012 Dec; 43(12):3305-12. PubMed ID: 23150653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of suPAR and hs-CRP on cardiovascular disease.
    Diederichsen MZ; Diederichsen SZ; Mickley H; Steffensen FH; Lambrechtsen J; Sand NPR; Christensen KL; Olsen MH; Diederichsen A; Grønhøj MH
    Atherosclerosis; 2018 Apr; 271():245-251. PubMed ID: 29402404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardio-Renal Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C-Reactive Protein, and Renal Function.
    Nikorowitsch J; Borchardt T; Appelbaum S; Ojeda F; Lackner KJ; Schnabel RB; Blankenberg S; Zeller T; Karakas M
    J Am Heart Assoc; 2020 Apr; 9(8):e015452. PubMed ID: 32299288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SuPAR is associated with death and adverse cardiovascular outcomes in patients with suspected coronary artery disease.
    Hodges G; Lyngbæk S; Selmer C; Ahlehoff O; Theilade S; Sehestedt TB; Abildgaard U; Eugen-Olsen J; Galløe AM; Hansen PR; Jeppesen JL; Bang CN
    Scand Cardiovasc J; 2020 Dec; 54(6):339-345. PubMed ID: 32400206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble urokinase plasminogen activator receptor: a risk factor for carotid plaque, stroke, and coronary artery disease.
    Persson M; Östling G; Smith G; Hamrefors V; Melander O; Hedblad B; Engström G
    Stroke; 2014 Jan; 45(1):18-23. PubMed ID: 24253546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.
    Eugen-Olsen J; Andersen O; Linneberg A; Ladelund S; Hansen TW; Langkilde A; Petersen J; Pielak T; Møller LN; Jeppesen J; Lyngbaek S; Fenger M; Olsen MH; Hildebrandt PR; Borch-Johnsen K; Jørgensen T; Haugaard SB
    J Intern Med; 2010 Sep; 268(3):296-308. PubMed ID: 20561148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes.
    Samman Tahhan A; Hayek SS; Sandesara P; Hajjari J; Hammadah M; O'Neal WT; Kelli HM; Alkhoder A; Ghasemzadeh N; Ko YA; Aida H; Gafeer MM; Abdelhadi N; Mohammed KH; Patel K; Arya S; Reiser J; Vaccarino V; Sperling L; Quyyumi A
    Atherosclerosis; 2017 Sep; 264():108-114. PubMed ID: 28728756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble urokinase plasminogen activator receptor as a long-term prognostic biomarker in acute coronary syndromes.
    Peiró ÓM; Cediel G; Bonet G; Rojas S; Quintern V; Carrasquer A; González-Del-Hoyo M; Sanz E; Bardají A
    Biomarkers; 2020 Jul; 25(5):402-409. PubMed ID: 32551985
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.
    Mekonnen G; Corban MT; Hung OY; Eshtehardi P; Eapen DJ; Al-Kassem H; Rasoul-Arzrumly E; Gogas BD; McDaniel MC; Pielak T; Thorball CW; Sperling L; Quyyumi AA; Samady H
    Atherosclerosis; 2015 Mar; 239(1):55-60. PubMed ID: 25574858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble urokinase plasminogen activator receptor and functionally relevant coronary artery disease: a prospective cohort study.
    Walter JE; Amrein MLF; Schäfer I; Zimmermann T; Lopez-Ayala P; Boeddinghaus J; Twerenbold R; Puelacher C; Nestelberger T; Wussler D; Honegger U; Badertscher P; Eugen-Olsen J; Koechlin L; Fahrni G; Jeger R; Kaiser C; Zellweger M; Mueller C
    Biomarkers; 2022 May; 27(3):278-285. PubMed ID: 35112976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.